Vuong Trieu - 10 Jul 2026 Form 4 Insider Report for Oncotelic Therapeutics, Inc. (OTLC)

Reporting relationship: CHAIRMAN AND CEO, Director, 10%+ Owner
Issuer ticker: OTLC
Reported as of: 10 Jul 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 14 Jul 2026, 16:00:19 UTC
Prior SEC filing: 02 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Vuong Trieu

Key filing fact

Vuong Trieu filed Form 4 for Oncotelic Therapeutics, Inc. (OTLC) on 14 Jul 2026.

Key facts

This page summarizes Vuong Trieu's Form 4 filing for Oncotelic Therapeutics, Inc. (OTLC).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 14 Jul 2026, 16:00.

Change

Previous filing in this sequence was filed on 02 Jul 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001587074 Primary reporting owner

Trieu Vuong

Relationship: CHAIRMAN AND CEO, Director, 10%+ Owner
Address: 29397 AGOURA RD SUITE 107, AGOURA HILLS
Signature: /s/ Vuong Trieu
Signature date: 14 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OTLC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 94,124,319
Date: 10 Jul 2026
Ownership: Direct

OTLC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 16,780,384
Date: 10 Jul 2026
Ownership: By Autotelic Inc.

OTLC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 6,872,529
Date: 10 Jul 2026
Ownership: By spouse

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OTLC transaction Derivative

Restricted stock Units

Award

Transaction value
Shares: +2,000
Change %
Price: $0.000000^*
Shares after: 2,000
Date: 10 Jul 2026
Ownership: Direct
Underlying class: Series A Preferred Stock
Underlying amount: 2,000
Exercise price: $0.000000
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

On July 10, 2026, the reporting person was granted 2,000 restricted stock units ("RSUs"), subject to performance and time-based vesting. On vesting each RSU will immediately be settled by delivery of, and each RSU represents the contingent right to receive, one share of the issuer's Series A Convertible Preferred Stock, par value $0.01. Each share of Series A Convertible Preferred Stock, in turn, is convertible into 1,000 shares of the issuer's common stock, par value $0.01 per share.

Footnote F2

The RSU's will vest upon (a) achievement of an uplisting of the issuer's common stock to a national securities exchange on or before June 30, 2027 (or such later date as the Board of Directors may approve), subject to the reporting person's continued service for a period of six months following the uplisting.